Intellia Therapeutics, Inc. (NTLA)

Intellia Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	226.75	523.51	123.41	160.02	57.23
Short-Term Investments	685.48	669.12	625.28	437.35	222.5
Cash & Cash Equivalents	912.22	1,193	748.69	597.37	279.73
Cash Growth	-23.51%	59.29%	25.33%	113.56%	-10.93%
Receivables	36.46	3.77	2.03	2.13	4.62
Other Current Assets	49.65	20.41	18.58	17.02	5.14
Total Current Assets	998.33	1,217	769.3	616.52	289.48
Property, Plant & Equipment	148.14	161	100.11	55.06	37.13
Long-Term Investments	154.51	142.32	425.05	4.75	4.75
Other Long-Term Assets	0	0	0	0	2.92
Total Long-Term Assets	302.65	303.32	525.16	59.81	44.8
Total Assets	1,301	1,520	1,294	676.32	334.28
Accounts Payable	7.45	5.15	9.65	10.46	3.94
Deferred Revenue	60.99	63.77	127.24	73.93	28.81
Current Debt	18.6	16.69	9.11	5.7	5.75
Other Current Liabilities	28.16	40.94	-20.17	-25.83	-2.86
Total Current Liabilities	115.21	126.55	125.83	64.25	35.63
Long-Term Debt	96.75	114.02	64.91	33.61	12.63
Other Long-Term Liabilities	38.85	43.96	63.48	51.39	16.14
Total Long-Term Liabilities	135.6	157.98	128.39	85	28.77
Total Liabilities	250.81	284.53	254.22	149.25	64.4
Total Debt	115.35	130.7	74.02	39.31	18.38
Debt Growth	-11.75%	76.57%	88.33%	113.90%	-
Retained Earnings	-1,658.38	-1,177.19	-703	-435.11	-300.88
Comprehensive Income	-2.26	-7.46	-2.63	0	0.26
Shareholders' Equity	1,050	1,236	1,040	527.07	269.88
Net Cash / Debt	796.88	1,062	674.67	558.07	261.35
Net Cash / Debt Growth	-24.96%	57.40%	20.89%	113.53%	-16.78%
Net Cash Per Share	8.98	13.80	9.52	9.97	5.53
Working Capital	883.12	1,090	643.47	552.26	253.85
Book Value Per Share	11.83	16.05	14.67	9.41	5.71

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).